Key facts
- This page summarizes Alan Lee Bazaar's Form 4 filing for Orthofix Medical Inc. (OFIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Mar 2024, 16:30.
Alan Lee Bazaar - 31 Jan 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)
- Reporting relationship
- Director
- Issuer ticker
- OFIX
- Reported as of
- 31 Jan 2024
- Net transaction value
- +$124,121
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2024, 16:30:32 UTC
- Prior SEC filing
- 20 Dec 2023
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberley A. Elting, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan Lee Bazaar filed Form 4 for Orthofix Medical Inc. (OFIX) on 12 Mar 2024.
Change
- Previous filing in this sequence was filed on 20 Dec 2023.
- Current net transaction value: +$124,121.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OFIX
transaction
Common Stock
Award
- Transaction value
- $124,121
- Shares
- +8,936
- Change %
- Price
- $13.89
- Shares after
- 8,936
- Date
- 31 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.